People

Pierre Detrixhe

Pierre Detrixhe

Pierre Detrixhe is Managing Partner at Financière spin-off luxembourgeoise and Venture Director at Newton Biocapital. He brings more than 10 years of experience in the field of venture capital and has accompanied many companies in the start-up phase. Previously, he held positions of scientist and technology transfer officer in the biotechnology field. Pierre Detrixhe is Director at the Board of some promising Belgian start-up companies. He holds a Master in Bioengineering from the University of Liège (Gembloux Agro-Bio Tech), Belgium and a Master in Management from the Catholic University of Louvain, Belgium. He brings more than 10 years of experience in the field of venture capital and has accompanied many companies in the start-up phase. Previously, he held positions of scientist and technology transfer officer in the biotechnology field. Pierre is Director of the Board of promising start-ups including Apaxen, ATB Therapeutics, Becarv, Bioxodes and Synergia Medical. He holds a Master in Bioengineering from the University of Liège (Gembloux Agro-Bio Tech) and a Master in Management from the Catholic University of Louvain, Belgium. Based in Belgium LinkedIn Newton Biocapital publicly documents this person as Venture Director. The affiliation is scoped to the published role, with no personal cash investment inferred. Pierre Detrixhe is publicly named by ORSA Fund (formerly Investsud) as Investment Manager. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role. Bioxodes affiliation: Pierre Detrixhe is Managing Partner at Financière spin-off luxembourgeoise and Venture Director at Newton Biocapital. He brings more than 10 years of experience in the field of venture capital and has accompanied many companies in the start-up phase. Previously, he held positions of scientist and technology transfer officer in the biotechnology field. Pierre Detrixhe is Director at the Board of some promising Belgian start-up companies. He holds a Master in Bioengineering from the University of Liège (Gembloux Agro-Bio Tech), Belgium and a Master in Management from the Catholic University of Louvain, Belgium.

Roles

Current
Newton Biocapital

Venture Director

Current
Current
ORSA Fund

Investment Manager

Current
Bioxodes

Non-Executive Director

Current